FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial

FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial

Submitted by admin on February 14, 2023 - 10:48am
Source: 
Clinical Trials Arena
News Tags: 
Pharmazz
sovateltide
stroke
cerebral ischemia
FDA
Headline: 
FDA clears Pharmazz’s IND for acute cerebral ischaemic stroke therapy trial
snippet: 

The US Food and Drug Administration (FDA) has issued a proceed forward letter for Pharmazz’s investigational new drug (IND) application to commence a Phase III clinical trial of Sovateltide (PMZ-1620) in acute cerebral ischaemic stroke patients.

Do Not Allow Advertisers to Use My Personal information